CHARLENE SHERO: Open Payments
NPI 1477634947 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 19 payments from 7 companies in 2025. Trend: 2023 $498 · 2024 $529 · 2025 $433
Food & beverage: $422Education: $11
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $140 |
| Teva Pharmaceuticals USA, Inc. | 2 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| ABBVIE INC. | 2 | $42 |
| Alkermes, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $19 |
Products named: INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, VRAYLAR, ARISTADA, REXULTI, ABILIFY ASIMTUFII, UZEDY.
Industry payments across TX — which companies pay providers there.
